Autoantibodies in epileptic patients indicate the autoimmune epilepsy

Author:

Naser Hajer N.1,Ali Naael H.2,Derraj Maysoon K.1

Affiliation:

1. Department of Medical Laboratory Technology, College of Health and Medical, Technology, Southern Technical University, Basrah, Iraq

2. Department of Clinical Immunity, College of Medicine, Basrah, Iraq

Abstract

Background Epilepsy is a multifaceted neurological condition marked by recurring seizures. Delving into the functions of VGKC (voltage-gated potassium channels), AMPA GluR3 (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor subunit 3), GAD65 (glutamate decarboxylase 65), and LGI1 (leucine-rich glioma-inactivated 1) in epilepsy yields significant perspectives into the fundamental immunological mechanisms of this disorder. Objective The study target was to assess the clinical significance of neural autoantibody biomarkers in patients with epilepsy and determine the types of autoimmune epilepsy. Materials and methods A case–control study that comprised 50 epilepsy patients (33 males and 17 females) and 40 controls (21 males and 19 females), the patients and controls attending Basrah Teaching Hospital between November 2022 and March 2023, Basrah City, Southern Iraq. The control age ranged from 2 to 62 years and patients’ age 2–68 years were considered the control group in this study. The VGKC, AMPA GluR3, GAD65, and LGI1 were measured using the sandwich ELISA technique. Results and conclusion There is no statistically significant difference between the patients and control group for VGKC, GAD65, and LGI1 (P=0.460, P=0.061, and P=0.440, respectively), while there is a statistically significant difference between the patients and the control group for AMPA GluR3 (P=0.012). GAD65 appeared an elevation in epilepsy patients but was not statistically significant. This upregulation may contribute to the hyperexcitability observed in the epileptic brain and potentially play a role in seizure generation and propagation.

Publisher

Medknow

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3